Cardinal Health SG&A increased by 2.5% to $1.54B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.3%, from $1.32B to $1.54B. Over 4 years (FY 2021 to FY 2025), SG&A shows an upward trend with a 4.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
Increases may indicate aggressive marketing or expansion, while decreases often reflect cost-cutting measures or improved corporate efficiency.
Detailed definition
The sum of all direct and indirect selling expenses and all general and administrative expenses of a company. This inclu...
Peer comparison
Used to assess the 'leaness' of a company's corporate structure relative to its peers.
Metric ID:
selling_general_and_administrativeHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.13B | $1.11B | $1.15B | $1.14B | $1.16B | $1.20B | $1.19B | $1.18B | $1.27B | $1.20B | $1.28B | $1.27B | $1.25B | $1.28B | $1.31B | $1.32B | $1.48B | $1.46B | $1.50B | $1.54B |
| QoQ Change | — | -1.3% | +3.3% | -1.2% | +1.6% | +3.6% | -0.5% | -1.0% | +7.5% | -5.5% | +7.2% | -1.1% | -1.4% | +2.1% | +2.3% | +0.7% | +12.9% | -1.5% | +2.9% | +2.5% |
| YoY Change | — | — | — | — | +2.3% | +7.5% | +3.5% | +3.7% | +9.7% | +0.0% | +7.7% | +7.6% | -1.3% | +6.7% | +1.8% | +3.6% | +18.6% | +14.4% | +15.2% | +17.3% |
Range$1.11B – $1.54B
CAGR+6.8%
Avg YoY Growth+7.4%
Median YoY Growth+7.1%
Current Streak2 quarters growth
Product Breakdown
| Segment | FY'21 | FY'22 | FY'23 | FY'24 | FY'25 |
|---|---|---|---|---|---|
| Shipping and Handling | $634.00M | $748.00M | $835.00M | $866.00M | $909.00M |
| Total | $4.53B | $4.56B | $4.83B | $5.00B | $5.38B |
All segment values are derived from annual filings.
Business Segments
| Segment | Q1 '26 |
|---|---|
| Pharmaceutical and Specialty Solutions | $732.00M |
| Cost of product sold | $518.00M |
| Other Segments | $259.00M |
| Total | $1.54B |
SG&A at Other Companies
Frequently Asked Questions
- What is Cardinal Health's sg&a?
- Cardinal Health (CAH) reported sg&a of $1.54B in Q1 2026.
- How has Cardinal Health's sg&a changed year-over-year?
- Cardinal Health's sg&a increased by 17.3% year-over-year, from $1.32B to $1.54B.
- What is the long-term trend for Cardinal Health's sg&a?
- Over 4 years (2021 to 2025), Cardinal Health's sg&a has grown at a 4.4% compound annual growth rate (CAGR), from $4.53B to $5.38B.
- What does sg&a mean?
- The day-to-day costs of running the business and marketing its products.